Total body water (~60% of weight) partitions into intracellular (2/3) and extracellular (1/3) fluid. These compartments maintain osmotic equilibrium because water freely crosses membranes while osmotically active solutes are compartmentalized. Vasopressin adjusts collecting duct permeability to preserve plasma osmolarity (~290 mOsm/L), while sodium content determines extracellular volume. Disturbances in either osmolarity or sodium alter water distribution and cellular function.
Start with the physics you already know from osmosis and tonicity: water moves across a semipermeable membrane toward the side with higher solute concentration until osmotic equilibrium is reached. The body applies this principle across two nested membranes — the cell membrane separating intracellular from extracellular fluid, and the capillary wall separating plasma from interstitial fluid. Because cell membranes are freely permeable to water but tightly control which solutes cross, the body can maintain very different solute compositions on each side while water distributes itself to equalize osmolarity (total solute concentration) across compartments.
The intracellular compartment (about 40% of body weight, or two-thirds of total body water) is dominated by potassium, phosphate, and large negatively charged proteins. The extracellular compartment (about 20% of body weight) is dominated by sodium and chloride. This asymmetry is actively maintained by the Na⁺/K⁺-ATPase pump in every cell membrane. Because sodium is the dominant extracellular solute, plasma osmolarity is approximated simply as 2 × [Na⁺] + glucose/18 + BUN/2.8. When sodium concentration rises, so does osmolarity — water shifts out of cells, concentrating intracellular contents and shrinking cells. When sodium falls, water shifts in, swelling cells. This is why osmolarity disturbances are clinically dangerous: neurons are particularly sensitive to shrinkage and swelling.
The body regulates osmolarity and volume through separate but interacting systems. Vasopressin (antidiuretic hormone, ADH) is released by the posterior pituitary when osmoreceptors in the hypothalamus detect plasma osmolarity rising above ~290 mOsm/L. It inserts aquaporin water channels into the collecting duct of the kidney, allowing more water to be reabsorbed and diluting the plasma back to normal. This is a pure osmolarity-correction mechanism — it moves water without moving sodium. Volume regulation, by contrast, is governed primarily by sodium balance: aldosterone promotes renal sodium (and thus water) retention when blood pressure falls. Understanding this distinction is crucial — a patient who is both hypovolemic and hyponatremic has two separate problems requiring different treatments.
Electrolytes do more than set osmotic pressure. Potassium's intracellular dominance sets the resting membrane potential of excitable cells (neurons, muscle). Calcium ions trigger muscle contraction and neurotransmitter release. Phosphate buffers intracellular pH and is the backbone of ATP. Hypokalemia flattens the resting membrane potential, making cells hyper-excitable (cardiac arrhythmias); hyperkalemia depolarizes cells to the point of inexcitability (cardiac arrest). These clinical consequences flow directly from the biophysics of ionic gradients you already know from cell membrane structure and colligative properties — the body is simply running those same principles at physiological scale, with hormonal feedback loops keeping the system within tight tolerances.